Skip to main content

Vancomycin clinical trials at University of California Health

1 research study open to eligible people

Showing trials for
  • Optimal Treatment for Recurrent Clostridium Difficile

    open to eligible people ages 18 years and up

    The purpose of this study is to determine whether fidaxomicin and vancomycin followed by taper and pulse vancomycin treatment are superior to standard vancomycin treatment for the treatment of recurrent Clostridium difficile infection.

    at UCSD

Last updated: